PolyActiva is a clinical-stage ophthalmology company that develops unique ocular implants to treat ocular diseases of the eye. Here is an update on PolyActiva’s drug delivery platform, showcasing its Latanoprost FA SR Ocular Implant for the treatment of glaucoma.
PolyActiva has developed the next generation technology that enable site-specific drug delivery. The unique technology allows for production of bespoke drug polymer conjugates. This video describes how the technology works.